Humana Inc.
Humana Inc. Responds to CMS's Preliminary 2025 Medicare Advantage Payment Rates
Summary
On January 31, 2024, CMS issued preliminary 2025 Medicare Advantage and Part D payment rates, proposing a 0.16 percent decrease in benchmark funding. Humana Inc. anticipates a more significant decrease based on its preliminary analysis, primarily due to proposed effective growth rate restatements and normalization factors. The company plans to provide formal commentary to CMS on the Advance Notice's impact on Medicare beneficiaries' care, affordability, and service. Humana Inc. maintains its 2025 outlook of $6 to $10 in Adjusted Earnings Per Share (EPS) growth despite the preliminary nature of the Advance Notice.
Get alerts for HUM
Be first to know when Humana Inc. files with the SEC.
Filing Categories
Advertisement
About Humana Inc.
Humana Inc. is a leading healthcare insurance company that primarily focuses on offering comprehensive health insurance products and services. It operates in the insurance sector and is a significant player in the Medicare Advantage market, providing coverage solutions for senior citizens eligible for Medicare. Additionally, Humana boasts a diverse range of health plans, including individual, group medical plans, and specialty products like dental and vision care. The company extends its services to various sectors, including government-sponsored healthcare programs and commercial employers, emphasizing wellness and preventive care. Humana’s offerings are designed to meet the needs of both individual consumers and large organizations, ensuring tailored healthcare coverage. Based in Louisville, Kentucky, Humana is a crucial component of the healthcare system in the United States, striving to improve health outcomes and provide affordable insurance options. The company continues to influence the healthcare industry by enhancing its digital solutions and fostering partnerships that promote integrated care between medical professionals and insurers.
Official SEC Documents
Advertisement